PLA2 activity regulates Ca2+ storage-dependent cellular proliferation.
The objective of this study is to determine the role of arachidonic acid (AA) in cell proliferation by inhibiting AA synthetic enzyme phospholipase A2 (PLA2) and to determine its involvement in the role of the second messenger intracellular calcium (Ca2+). Methods used to determine the effects on proliferation of cell cultures of primary meningioma and astrocytoma U373-MG included treatment with micromolar concentrations of PLA2 inhibitors 4-bromophenacylbromide and quinacrine. Effects of these drugs on proliferation were further investigated by the application of concentrations that inhibit growth by 50% while antagonizing these agents with AA replacement. Free cytosolic Ca2+ was measured with the use of fluorescent dye Fura-2 during PLA2 agonist/antagonist studies. These Ca2+ measurements were performed in the absence of extracellular Ca2+ to identify the contribution of intracellular Ca2+ sources. PLA2 inhibition resulted in decreased growth of cultured astrocytoma and meningioma cells in a dose-dependent manner in the micromolar range. This inhibitory effect was antagonized by the addition of AA. PLA2 inhibition caused an elevation of basal-cytosolic-free [Ca2+] while depleting internal Ca2+ stores. These Ca2+ changes were also antagonized by the addition of AA. In conclusion, these results demonstrate that AA, a PLA2 enzyme product, is involved in regulating the growth rate of these cell types. The PLA2 pathway also regulates the maintenance of the internal Ca2+ stores. Ca2+ is known to be a growth-related intracellular second messenger. These results suggest that the growth regulatory functions of AA are mediated by Ca2+-dependent mechanisms.
Loyola University Medical Center, Stritch School of Medicine, Maywood, Illinois, 60153, USA.
M J
MJ
Petr
T C
TC
Origitano
R D
RD
Wurster
D001254:Astrocytoma / Q000201:enzymology; D002118:Calcium / Q000819:agonists / Q000037:antagonists & inhibitors; D020013:Calcium Signaling / Q000502:physiology*; D002455:Cell Division / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D015777:Eicosanoids / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D006131:Growth Inhibitors / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology; D006801:Humans; D008297:Male; D008579:Meningioma / Q000201:enzymology; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000502:physiology*; D054467:Phospholipases A2; D014407:Tumor Cells, Cultured
D015777:Eicosanoids; D006131:Growth Inhibitors; D010741:Phospholipases A; D054467:Phospholipases A2; D002118:Calcium